Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits.
Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits.
复制标题
DOI:
10.1161/circgenetics.111.961482
复制
发表时间:
2012-04-01
期刊:
影响因子:
--
通讯作者:
Salomaa V
中科院分区:
文献类型:
--
作者:
Kristiansson K;Perola M;Tikkanen E;Kettunen J;Surakka I;Havulinna AS;Stancáková A;Barnes C;Widen E;Kajantie E;Eriksson JG;Viikari J;Kähönen M;Lehtimäki T;Raitakari OT;Hartikainen AL;Ruokonen A;Pouta A;Jula A;Kangas AJ;Soininen P;Ala-Korpela M;Männistö S;Jousilahti P;Bonnycastle LL;Järvelin MR;Kuusisto J;Collins FS;Laakso M;Hurles ME;Palotie A;Peltonen L;Ripatti S;Salomaa V
Genome-wide association (GWA) studies have identified several susceptibility loci for metabolic syndrome (MetS) component traits, but have had variable success in identifying susceptibility loci to the syndrome as an entity. We conducted a GWA study on MetS and its component traits in four Finnish cohorts consisting of 2637 MetS cases and 7927 controls, both free of diabetes, and followed the top loci in an independent sample with transcriptome and NMR-based metabonomics data. Furthermore, we tested for loci associated with multiple MetS component traits using factor analysis and built a genetic risk score for MetS. A previously known lipid locus, APOA1/C3/A4/A5 gene cluster region (SNP rs964184), was associated with MetS in all four study samples (P=7.23×10−9 in meta-analysis). The association was further supported by serum metabolite analysis, where rs964184 associated with various VLDL, TG, and HDL metabolites (P=0.024-1.88×10−5). Twenty-two previously identified susceptibility loci for individual MetS component traits were replicated in our GWA and factor analysis. Most of these associated with lipid phenotypes and none with two or more uncorrelated MetS components. A genetic risk score, calculated as the number of alleles in loci associated with individual MetS traits, was strongly associated with MetS status. Our findings suggest that genes from lipid metabolism pathways have the key role in the genetic background of MetS. We found little evidence for pleiotropy linking dyslipidemia and obesity to the other MetS component traits such as hypertension and glucose intolerance.